Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The combined analysis of microbiome, immunological parameters and host genetics in patients has potential for applying personalized approaches of prevention, diagnostics or therapy in the future. However, the acquisition and analysis of these patient characteristics in a scientifically sound, technically reliable, cost-effective, practicable and future-oriented fashion are a far from trivial task. Therefore the objectives of the study are (i) to optimize a sample and data acquisition and analysis pipeline that fulfills these criteria (using samples from healthy volunteers); (ii) validate the pipeline in a cohort of children undergoing stem cell transplantation, yielding information on host immuno-genetics, gut immune function and the human gut microbiome; (iii) deduct the most critical parameters for host-microbiome interplay from this complex dataset.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Stem cell transplant recipient |
| ||
| Stem cell donor |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Stem cell transplantation | Other | Intervention is not conducted as part of the study but patients at Tübingen University Hospital undergoing this intervention as part of their standard care are being monitored in this observational study. |
| Measure | Description | Time Frame |
|---|---|---|
| Immune system - intestinal microbiota co-re-emergence after myeloablative conditioning and antibiotics treatment, respectively. | through study completion, anticipated after 2 years |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Patients undergoing stem cell transplantation due to hematological malignancies Allogeneic stem cell donors
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Alexander NR Weber, PhD | Contact | +49 7071 29 | 87623 | alexander.weber@uni-tuebingen.de |
| Silke Peter, MD | Contact | +49 7071 29 | 81527 | silke.peter@med.uni-tuebingen.de |
| Name | Affiliation | Role |
|---|---|---|
| Alexander NR Weber, PhD | University Hospital Tuebingen | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Children's Hospital Tübingen | Recruiting | Tübingen | 72076 | Germany |
Not provided
| ID | Term |
|---|---|
| D033581 | Stem Cell Transplantation |
| ID | Term |
|---|---|
| D017690 | Cell Transplantation |
| D064987 | Cell- and Tissue-Based Therapy |
| D001691 | Biological Therapy |
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Not provided
Not provided
Urine Feces Blood
| D014180 |
| Transplantation |
| D013514 | Surgical Procedures, Operative |